While headlines might boast about increasing enrollment in Medicare Advantage (MA) plans, with over 50% of eligible beneficiaries now opting for these private insurer-run versions of Medicare, the reality beneath the surface reveals a troubling picture. The year 2023, far from being a triumph for Medicare Advantage, exposed significant cracks in its foundation, signaling deeper systemic issues that should concern patients, taxpayers, and even investors.
Financial Instability Shakes the Medicare Advantage Market
The financial health of Medicare Advantage insurers experienced a jolt in early 2023, with stock prices of major players dramatically declining after disappointing earnings reports. Companies heavily invested in MA, such as Humana, CVS Health, and UnitedHealth Group, witnessed significant losses. Humana, particularly vulnerable due to its business model’s reliance on MA, saw its stock plummet by an alarming 14.2%. These financial setbacks weren’t isolated incidents. Insurers attributed these losses to higher-than-anticipated healthcare utilization rates among MA enrollees and cautioned that this trend was likely to persist into 2024. Adding to the financial uncertainty, private equity investment in Medicare Advantage has also decreased, indicating a growing lack of confidence in the program’s long-term viability.
The Mounting Criticisms and Failures of Medicare Advantage
Beyond the financial turmoil, Medicare Advantage faces a growing chorus of criticism from various corners, highlighting fundamental flaws within the program. Legislators from across the political spectrum are raising concerns about substantial overpayments to MA plans. Experts estimate these overpayments to be as high as $140 billion annually, diverting crucial funds from the Medicare system. Beneficiaries themselves are increasingly reporting feeling “trapped” in MA plans, lured by initial promises of comprehensive coverage and low costs, only to encounter denied treatments and escalating medical bills when they actually need care. Reports indicate that Medicare Advantage patients experience more delays in care approvals compared to those in traditional Medicare, with 22% of MA patients reporting such delays versus 13% in traditional Medicare. Hospitals, too, are voicing their discontent, with a growing number refusing to accept Medicare Advantage plans altogether, citing inadequate reimbursement rates and the excessive administrative burden of prior authorization processes.
Profit-Driven Care: The Core Problem with Medicare Advantage
The fundamental issue plaguing Medicare Advantage lies in its inherent structure: it’s a profit-driven model operating within a healthcare system designed for patient well-being. Private insurers administering MA plans are incentivized to maximize profits, which often translates to minimizing care delivery. This is achieved through various tactics, notably “upcoding,” where insurers inflate patient diagnoses to receive larger payments from Medicare without providing additional necessary care. Furthermore, MA plans often create bureaucratic hurdles and implement stringent pre-authorization requirements, effectively delaying or denying necessary treatments to control costs and boost their bottom line. This focus on cost-cutting within a for-profit framework directly compromises patient care and access to timely medical services.
Investor Confidence Wanes as Reality Sets In
For years, investors operated under certain assumptions about Medicare Advantage: that insurers could effectively manage and limit enrollees’ healthcare utilization, that government overpayments would continue unabated, and that the lucrative business model would persist. However, the recent financial downturn and mounting criticisms have shattered these assumptions. Investors are now recognizing the inherent instability and ethical concerns within the MA system. The realization that these plans cannot perpetually control healthcare costs and that regulatory scrutiny is increasing has led many to divest from MA companies, further contributing to the program’s financial precariousness.
Traditional Medicare: A Superior and More Efficient System
In stark contrast to the complexities and inherent flaws of Medicare Advantage, traditional Medicare offers a more straightforward and efficient approach to healthcare coverage for seniors. Traditional Medicare operates with significantly lower administrative overhead and spends less per patient overall while providing beneficiaries with broader access to doctors, hospitals, and specialized treatments. The simplicity of the approval process in traditional Medicare stands in sharp relief to the often-labyrinthine authorization procedures within MA plans. Traditional Medicare prioritizes patient access and care quality over profit maximization, making it a fundamentally more patient-centered system.
Strengthening Traditional Medicare: The Path Forward
While traditional Medicare isn’t without its areas for improvement, it provides a robust foundation for a better healthcare system for seniors. The allure of Medicare Advantage, with its promises of low premiums and supplementary benefits like dental, vision, and hearing coverage, often overshadows the limitations and potential pitfalls of these plans. However, these supplementary benefits should not be exclusive to MA. Traditional Medicare can and should be enhanced to include similar benefits, funded in part by redirecting the billions of dollars currently wasted on MA overpayments. By strengthening traditional Medicare and expanding its benefits, we can create a truly competitive healthcare landscape where patients choose the program that genuinely serves their needs, leading to better health outcomes, reduced government spending, and fewer healthcare-related anxieties for seniors.
Conclusion: Time to Recommit to Traditional Medicare
Medicare Advantage is demonstrably failing across the board – for the government, for patients, for taxpayers, and increasingly, even for investors. The evidence is clear: it is time to shift our focus and resources towards strengthening and supporting traditional Medicare. This proven system, with necessary enhancements, offers a more equitable, efficient, and patient-centered path forward for senior healthcare in the United States.
About the Authors
Wendell Potter is former VP, corporate communications, Cigna, and publisher of HEALTH CARE un-covered. @wendellpotter
Philip Verhoef, M.D., Ph.D., is an intensivist and associate clinical professor of medicine at the John A. Burns School of Medicine, University of Hawaii-Manoa. He is the president of Physicians for a National Health Program. @DrPhilipVerhoef
Tags
CMS Medicare
